Skip to main content

Table 5 Comparison of adverse effect that occurred in patients with pulmonary Mycobacterium avium complex disease between the control and levofloxacin (LVFX) groups

From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

Adverse effects Control group (n = 57) LVFX group (n = 18)
Skin manifestation 9 (16) 4 (22)
Visual impairment 7 (12) 2 (11)
Gastrointestinal symptom 6 (11) 3 (17)
Hepatic dysfunction 1 ( 2 ) 2 (11)
Miscellaneous 3 ( 5 ) 1 ( 1 )
Total 21 (37) 10 (56)
  1. Values express as number (%) of patients. There was no significant difference in total and each adverse effect between both groups